✦ LIBER ✦

Current concerns in the therapy of neuromuscular disorders

✍ Scribed by Victor Dubowitz

Book ID: 116794735
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 62 KB
Volume: 21
Category: Article
ISSN: 0960-8966
DOI: 10.1016/j.nmd.2010.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The current place of high-dose immunoglo

The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders

✍ Frans G. A. van der Meché; Pieter A. van Doorn 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

High-dose immunoglobulins for intravenous administration (IVIg) have originally been developed for substitution therapy in hypogammaglobulinemia. Over the last decade they are increasingly used in the treatment of immunemediated diseases. In this review the results in immune-mediated neuromuscular d

Current methodological issues in the stu

Current methodological issues in the study of children with inherited neuromuscular disorders

✍ Eugenio Mercuri; Sonia Messina; Marika Pane; Enrico Bertini 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Current status on electrodiagnostic stan

Current status on electrodiagnostic standards and guidelines in neuromuscular disorders

✍ Anders Fuglsang-Frederiksen; Kirsten Pugdahl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 535 KB

Current therapies for neuromuscular mani

Current therapies for neuromuscular manifestations of paraneoplastic syndromes

✍ Myrna R. Rosenfeld; Josep Dalmau 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 129 KB

Concerns regarding the current use of β-

Concerns regarding the current use of β-agonists in the therapy of asthma

✍ Gunnar Aberg; John Costello 📂 Article 📅 1996 🏛 Humana Press Inc 🌐 English ⚖ 260 KB

Maintenance therapy in the myeloprolifer

Maintenance therapy in the myeloproliferative disorders: the current options

✍ Francis J. Giles 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB